Bespoken Nanoceria: An Effective Treatment in Experimental Hepatocellular Carcinoma

BACKGROUND AND AIMS: Despite the availability of new‐generation drugs, hepatocellular carcinoma (HCC) is still the third most frequent cause of cancer‐related deaths worldwide. Cerium oxide nanoparticles (CeO(2)NPs) have emerged as an antioxidant agent in experimental liver disease because of their...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernández‐Varo, Guillermo, Perramón, Meritxell, Carvajal, Silvia, Oró, Denise, Casals, Eudald, Boix, Loreto, Oller, Laura, Macías‐Muñoz, Laura, Marfà, Santi, Casals, Gregori, Morales‐Ruiz, Manuel, Casado, Pedro, Cutillas, Pedro R., Bruix, Jordi, Navasa, Miquel, Fuster, Josep, Garcia‐Valdecasas, Juan Carlos, Pavel, Mihai C., Puntes, Víctor, Jiménez, Wladimiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7702051/
https://www.ncbi.nlm.nih.gov/pubmed/31961955
http://dx.doi.org/10.1002/hep.31139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7702051/
https://www.ncbi.nlm.nih.gov/pubmed/31961955
http://dx.doi.org/10.1002/hep.31139

Ejemplares similares